Clinical Trial Update: A Study of KW-6356 in Subjects With Early Parkinson's Disease [Phase 2]

View source ↗

Summary

A Phase 2 trial of KW-6356 in early Parkinson's disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• KW-6356

Snippet

Sponsor: Kyowa Kirin Co., Ltd. | Conditions: Parkinson's Disease | Phase 2 | Status: COMPLETED